Delivery Order SPE2DR25D1034-SPE2DR26FPW7W
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,117.55 to AmerisourceBergen Drug Corp on December 15, 2025, with an ultimate completion date of December 16, 2025. This is a firm fixed price delivery order issued under a larger contract vehicle and represents a non-competitive award to the prime contractor. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor...
- The Defense Logistics Agency awarded a delivery order valued at $83,743.39 to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies on December 7, 2025. This competitively awarded, firm fixed-price delivery order is set to be completed by December 8, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,540.52 to AmerisourceBergen Drug Corp on December 1, 2025, with an ultimate completion date of December 22, 2025. This firm fixed price, non-set-aside contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The work will be performed at AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $6,457.59 to AmerisourceBergen Drug Corp on December 2, 2025, for pharmaceutical products and medical supplies. This competitive award, with an ultimate completion date of December 3, 2025, utilizes firm fixed-price pricing and is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order will...
- The Defense Logistics Agency awarded a $17,687.66 delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, with a completion date of December 23, 2025. This competitively awarded, firm fixed-price contract involves the delivery of pharmaceutical products and medical supplies to support federal medical procurement needs. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $1,085.04 to AmerisourceBergen Drug Corp on December 17, 2025, for pharmaceutical products and medical supplies. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The work will be performed at the contractor's corporate...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $45,278.31 on July 28, 2025, by the Defense Logistics Agency's Medical Supply Chain with a completion date of July 29, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order valued at $8,865.50 to AmerisourceBergen Drug Corp on December 30, 2025, for pharmaceutical products and services. This firm fixed-price delivery order, which extends through December 31, 2025, represents a non-competitive award issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,573.26 on December 3, 2025, with an ultimate completion date of December 4, 2025. This firm fixed-price contract, issued by the Defense Logistics Agency's Medical Supply Chain division, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,909.80 to AmerisourceBergen Drug Corp on December 4, 2025, with an ultimate completion date of December 5, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply fulfillment. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DR25D1034Indefinite Delivery Contract
- SPE2DR25D1034-SPE2DR26FPW7WDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for pharmaceutical supplies valued at $1,184.60, with completion scheduled for January 22, 2026. The award covers a 0.25% drop formulation in 10ml units and was competitively awarded without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs, including the Defense Health Agency and U.S. Coast Guard. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse medical supply requirements through firm fixed-price delivery orders across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 12/29/25 |